Evaluation of pharmacokinetics, safety, and efficacy of [211At] meta-astatobenzylguanidine ([211At] MABG) in patients with pheochromocytoma or paraganglioma (PPGL): A study protocol.
Masao KobayakawaTohru ShigaKazuhiro TakahashiShigeyasu SugawaraKaori NomuraKazuhiko HanadaNaoki IshizukaHiroshi ItoPublished in: PloS one (2024)
jRCT2021220012 registered on 17 June 2022.